The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments Ian R. A. MackenzieRosa Rademakers Review Article 06 September 2007 Pages: 237 - 248
CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations Katrin VossSonja StahlUte Felbor Original Article 27 July 2007 Pages: 249 - 256
Functional, histopathologic and natural history study of neuropathy associated with EGR2 mutations Kinga SzigetiWojciech WiszniewskiJames R. Lupski Original Article 24 August 2007 Pages: 257 - 262
Evidence of shared risk for Alzheimer’s disease and Parkinson’s disease using family history Ami R. RosenN. Kyle SteenlandAllan I. Levey Original Article 06 September 2007 Pages: 263 - 270
Robust quantification of the SMN gene copy number by real-time TaqMan PCR Ilsa Gómez-CuretKaryn G. RobinsonWenlan Wang Original Article 24 July 2007 Pages: 271 - 278
Novel POMGnT1 mutations define broader phenotypic spectrum of muscle–eye–brain disease Ute HehrGoekhan UyanikJürgen Winkler Original Article 29 September 2007 Pages: 279 - 288
Frataxin gene point mutations in Italian Friedreich ataxia patients Cinzia GelleraBarbara CastellottiFranco Taroni Original Article 17 August 2007 Pages: 289 - 299
SPG11: a consistent clinical phenotype in a family with homozygous Spatacsin truncating mutation Roberto Del BoAlessio Di FonzoGiacomo Pietro Comi Original Article 24 August 2007 Pages: 301 - 305
Refinement of the SPG15 candidate interval and phenotypic heterogeneity in three large Arab families Nizar ElleuchNaima BouslamGiovanni Stevanin Original Article 28 July 2007 Pages: 307 - 315
An SPG3A whole gene deletion neither co-segregates with disease nor modifies phenotype in a hereditary spastic paraplegia family with a pathogenic SPG4 deletion Christian BeetzAnders O. H. NygrenEvan Reid Letter to the Editors 27 July 2007 Pages: 317 - 318